Science & Enterprise subscription

Follow us on Twitter

  • New contributed post on Science and Enterprise: https://t.co/MCiZyaoc0I Ships Are Becoming Safer With Technology
    about 2 hours ago
  • A panel of data and behavioral scientists envision great potential for blockchain in science, but show few cases o… https://t.co/Ch0yJRek4W
    about 22 hours ago
  • New post on Science and Enterprise: Blockchain and Science, Not Ready for Prime Time https://t.co/mYiRQ0j8vU #Science #Business #AAASmtg
    about 22 hours ago
  • New contributed post on Science and Enterprise: https://t.co/PCF9Fl0z3W Slips And Falls, Underestimated Workplace Hazards
    about 23 hours ago
  • An experimental drug is shown in a clinical trial and computer modeling to reduce the mass of smooth muscle tissue… https://t.co/oPx7X3lLzc
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

In Case You Missed It …

(tigerlily713, Pixabay)

5 August 2018. If you want a preview of the impact artificial intelligence can make on our life and work, read our story this past week about a project at University of North Carolina in Chapel Hill. A bioinformatics team at the school’s pharmacy school developed a system combining machine learning and neural networks with large-scale databases to design entirely new drug molecules that meet targeted chemical properties and biological activity.

In this case, the system known as Reinforcement Learning for Structural Evolution or Release, uses reinforcement learning in a two-stage process to design drug molecules from scratch. The system seeks to harness the power of artificial intelligence to speed the design of new and more complex therapies. As a proof-of-concept, the UNC team applied the Release system to design inhibitors of a protein called Janus kinase 2, or JAK2, from a gene that codes for stimulating growth and proliferation of cells.

Here are other stories we covered last week:

*     *     *

 

Please share Science & Enterprise ...

Comments are closed.